Tatjana Jankevic
Research Subjects
Tatjana Jankevic has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Dmitry Yurievich Trofimov
National Medical Research Center for Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov, Akademika Oparina St., 4, 117997 Moscow, Russia
5 shared publications - Gennady Tikhonovich Sukhikh
National Medical Research Center for Obstetrics Gynecology and Perinatology Named after Academician V.I. Kulakov of the Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia
4 shared publications - Aleksandr A. Romanko
Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, 197758 St.-Petersburg, Russia
3 shared publications - Liubov Valentinovna Krechetova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology Ministry of Health of Russian Federation
3 shared publications - Olga Vladimirovna Khoroshkeeva
National Medical Research Center for Obstetrics, Gynecology and Perinatology
3 shared publications - Sergey Petrovich Krechetov
Moscow Institute of Physics and Technology (National Research University)
3 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 72 (3)
Role of HLA Genotypes in the Age Variability at Onset of BRCA1-Associated Breast Cancer
Введение. Носительницы патогенных вариантов гена BRCA1 характеризуются значительной вариабельностью возраста манифестации рака молочной железы (РМЖ). HLA I и II классов играют ключевую роль в презентации опухолевых антигенов, однако существующие полногеномные исследования ассоциаций (GWAS) не позволяют оценить их вклад в модификацию пенетрантности из-за высокой полиморфности и структурной сложности этого региона генома, вследствие чего роль генотипов HLA в возраст-зависимой реализации риска BRCA1-ассоциированного РМЖ остается неизученной. Цель. Оценить связь генотипов локусов HLA I и II классов, а также гомозиготности HLA с возрастом манифестации РМЖ у носительниц мутаций BRCA1. Материалы и методы. В исследование включено 323 носительницы патогенных аллелей BRCA1 с верифицированным РМЖ из России и Польши, разделенные на группы с ранним (≤ 39 лет, n = 215) и поздним (≥ 57 лет, n = 108) дебютом заболевания. HLA-типирование локусов А, В, С, DPB1, DQB1, DRB1/3/4/5 выполняли методом высокопроизводительного секвенирования (NGS). Частоты аллелей и долю гомозиготных генотипов сравнивали с использованием критерия χ² и точного критерия Фишера; рассчитывали отношение рисков (ОР). Результаты. Аллель HLA-DQB1*06:03P статистически значимо чаще встречался в группе с поздним началом РМЖ по сравнению с группой раннего дебюта (13,8 против 5,1 %; ОР = 2,91 (95 % ДИ 1,62–5,22); p = 0,0001). Аллель HLA-C*03:04P ассоциирован с повышенным риском ранней манифестации (7,7 против 3,2 %; p = 0,027). Обнаружена статистически значимая связь гомозиготности по локусу HLA-A с развитием РМЖ в молодом возрасте (14,4 против 6,5 %; ОР = 2,4 (95 % ДИ: 1,03–5,72); p = 0,037). Для остальных локусов HLA класса I прослеживалась аналогичная тенденция к преобладанию гомозигот у пациенток с ранним дебютом. Выводы. Генотип HLA может модифицировать возраст-зависимую пенетрантность патогенных мутаций BRCA1. Наличие аллеля HLA-DQB1*06:03P ассоциировано с отсроченным развитием РМЖ; гомозиготность по локусам HLA класса I способствует более ранней реализации онкологического риска.
- 3 July 2026
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 72 (3)
Open AccessRole of HLA Genotypes in the Age Variability at Onset of BRCA1-Associated Breast Cancer
Введение. Носительницы патогенных вариантов гена BRCA1 характеризуются значительной вариабельностью возраста манифестации рака молочной железы (РМЖ). HLA I и II классов играют ключевую роль в презентации опухолевых антигенов, однако существующие полногеномные исследования ассоциаций (GWAS) не позволяют оценить их вклад в модификацию пенетрантности из-за высокой полиморфности и структурной сложности этого региона генома, вследствие чего роль генотипов HLA в возраст-зависимой реализации риска BRCA1-ассоциированного РМЖ остается неизученной. Цель. Оценить связь генотипов локусов HLA I и II классов, а также гомозиготности HLA с возрастом манифестации РМЖ у носительниц мутаций BRCA1. Материалы и методы. В исследование включено 323 носительницы патогенных аллелей BRCA1 с верифицированным РМЖ из России и Польши, разделенные на группы с ранним (≤ 39 лет, n = 215) и поздним (≥ 57 лет, n = 108) дебютом заболевания. HLA-типирование локусов А, В, С, DPB1, DQB1, DRB1/3/4/5 выполняли методом высокопроизводительного секвенирования (NGS). Частоты аллелей и долю гомозиготных генотипов сравнивали с использованием критерия χ² и точного критерия Фишера; рассчитывали отношение рисков (ОР). Результаты. Аллель HLA-DQB1*06:03P статистически значимо чаще встречался в группе с поздним началом РМЖ по сравнению с группой раннего дебюта (13,8 против 5,1 %; ОР = 2,91 (95 % ДИ 1,62–5,22); p = 0,0001). Аллель HLA-C*03:04P ассоциирован с повышенным риском ранней манифестации (7,7 против 3,2 %; p = 0,027). Обнаружена статистически значимая связь гомозиготности по локусу HLA-A с развитием РМЖ в молодом возрасте (14,4 против 6,5 %; ОР = 2,4 (95 % ДИ: 1,03–5,72); p = 0,037). Для остальных локусов HLA класса I прослеживалась аналогичная тенденция к преобладанию гомозигот у пациенток с ранним дебютом. Выводы. Генотип HLA может модифицировать возраст-зависимую пенетрантность патогенных мутаций BRCA1. Наличие аллеля HLA-DQB1*06:03P ассоциировано с отсроченным развитием РМЖ; гомозиготность по локусам HLA класса I способствует более ранней реализации онкологического риска.
- Open Access
- 1 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11638
Antibody-Dependent Cytotoxicity of Monocytes in Preeclampsia Is Associated with Soluble Forms of HLA
Preeclampsia (PE) is a serious gestational complication that affects the lives of the mother and the child. Women with PE showed higher levels of pro-inflammatory cytokines secreted by leukocytes compared with women with normal pregnancies. The differences are most noticeable in the percentage of CD16+ monocytes, although the mechanism underlying this increase remains unclear. The CD16 receptor is critical for antibody-dependent cellular cytotoxicity, and by binding to antibodies on the surface of target cells, it activates their death. In this study, we examined the effect of soluble placental factors on the expression of CD16 monocytes and the potential role the soluble form of human leukocyte antigen (HLA) has on CD16 monocyte expression. At the first stage of our study, we collected samples of placental villi fragments from 58 pregnant women (38 women with PE and 20 with a healthy pregnancy). Then we studied the effect of placental villus-conditioned culture medium on CD16 expression by monocytes derived from the same women. It was shown that the content of CD16+ monocytes increased significantly in women with PE within 3 h and to a lesser extent in women with a healthy pregnancy (p = 0.009). Also, the addition of the recombinant histocompatibility HLA-B to the placental villus-conditioned culture medium blocks the induction of CD16 expression on monocytes. At the second stage of our study, we typed HLA class I and class II alleles in the umbilical cord blood samples and the venous blood samples taken from 38 women with PE and 40 women with a normal pregnancy. It was found that certain HLA class II alleles predominate in women with preeclampsia. The DRB1*01:01:01G allele showed the greatest difference (p < 0.001). Analyzing five alleles simultaneously makes it possible to predict the PE with AUC = 0.76. Evaluation of unique children’s alleles also showed that class II alleles have greater differences among them than class I alleles. The DQB1*06:03:01G allele had the greatest differences with p = 0.03 (the number was higher in the control group). Performing an analysis of four alleles of children simultaneously allowed us to predict PE with an AUC of 0.64. This work suggests that the activation of CD16+ monocyte expression occurs due to the interaction of soluble placental antigens with monocytes. The most likely way to activate CD16 expression on monocytes is by HLA class II (both maternal and fetal) interaction with CD4 receptors on the surface of monocytes, whereas HLA class I is capable of blocking this process. Evaluation of maternal HLA alleles may be a significant marker for predicting PE.
- 1 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11638
Open AccessAntibody-Dependent Cytotoxicity of Monocytes in Preeclampsia Is Associated with Soluble Forms of HLA
Preeclampsia (PE) is a serious gestational complication that affects the lives of the mother and the child. Women with PE showed higher levels of pro-inflammatory cytokines secreted by leukocytes compared with women with normal pregnancies. The differences are most noticeable in the percentage of CD16+ monocytes, although the mechanism underlying this increase remains unclear. The CD16 receptor is critical for antibody-dependent cellular cytotoxicity, and by binding to antibodies on the surface of target cells, it activates their death. In this study, we examined the effect of soluble placental factors on the expression of CD16 monocytes and the potential role the soluble form of human leukocyte antigen (HLA) has on CD16 monocyte expression. At the first stage of our study, we collected samples of placental villi fragments from 58 pregnant women (38 women with PE and 20 with a healthy pregnancy). Then we studied the effect of placental villus-conditioned culture medium on CD16 expression by monocytes derived from the same women. It was shown that the content of CD16+ monocytes increased significantly in women with PE within 3 h and to a lesser extent in women with a healthy pregnancy (p = 0.009). Also, the addition of the recombinant histocompatibility HLA-B to the placental villus-conditioned culture medium blocks the induction of CD16 expression on monocytes. At the second stage of our study, we typed HLA class I and class II alleles in the umbilical cord blood samples and the venous blood samples taken from 38 women with PE and 40 women with a normal pregnancy. It was found that certain HLA class II alleles predominate in women with preeclampsia. The DRB1*01:01:01G allele showed the greatest difference (p < 0.001). Analyzing five alleles simultaneously makes it possible to predict the PE with AUC = 0.76. Evaluation of unique children’s alleles also showed that class II alleles have greater differences among them than class I alleles. The DQB1*06:03:01G allele had the greatest differences with p = 0.03 (the number was higher in the control group). Performing an analysis of four alleles of children simultaneously allowed us to predict PE with an AUC of 0.64. This work suggests that the activation of CD16+ monocyte expression occurs due to the interaction of soluble placental antigens with monocytes. The most likely way to activate CD16 expression on monocytes is by HLA class II (both maternal and fetal) interaction with CD4 receptors on the surface of monocytes, whereas HLA class I is capable of blocking this process. Evaluation of maternal HLA alleles may be a significant marker for predicting PE.
- Open Access
Natural killers in pregnancy: servants of two masters
The absence of maternal immune rejection of a haploidentical fetus remains unexplained. We hypothesize that the presence of different HLA antigens on trophoblasts and maternal cells via killer cell immunoglobulin-like receptors (KIRs) provides two-way tuning (education) of decidual natural killer cells (dNK) with the appearance of allo- (HvG) and autoreactive (HvH) dNK. Disturbances in dNK HvG and dNK HvH representation may lead to abnormalities in placental development and pregnancy pathology. Our data show that recurrent pregnancy loss is not associated with specific HLA and KIR genotypes in mother and fetus, although the peculiarities of tuning involving KIR3DL2 may affect pregnancy outcome. Mathematical modeling shows the dependence of dNK HvG and dNK HvH representation on the probability of random KIR gene expression. The new description of NK cell involvement in the immune response in the placenta via two-way tuning is applicable to all cases where there are target cells with normal and different “guest” HLA expression (viral infections, tumors, etc.) Graphic abstract (Cover work): Image of fetus in utero in graphic abstract adapted from Servier Medical Art ( https://smart.servier.com ), licensed under CC BY 4.0 ( https://creativecommons.org/licenses/by/4.0/ ) Highlights: A hypothesis has been proposed according to which random expression of NK cell receptor genes in combination with two-way tuning (education) of NK cells by different affinity pairs of inhibitory killer cell immunoglobulin-like receptors (KIRs) and their ligands on decidual cells and trophoblasts leads to the presence of populations of maternal decidual NK cells with allo- and autoreactivity in the placenta. It has been shown that the features of the HLA and KIR genotypes of the mother and fetus are not the underlying cause of habitual miscarriage, although genetic features can affect the course of pregnancy. Model calculations of the representation of auto- and alloreactive maternal decidual NK cells show that the effectiveness of their participation in the structural and functional reorganization of the placenta should depend on the probability of KIR gene expression. The hypothesis of two-way tuning of NK cells in the presence of different target cells with normal and different “guest” HLA expressions is applicable to describe the involvement of the innate immune system in the response to pregnancy, viral infection, inflammation, wounds, tumors, and transplantation.
Open AccessNatural killers in pregnancy: servants of two masters
The absence of maternal immune rejection of a haploidentical fetus remains unexplained. We hypothesize that the presence of different HLA antigens on trophoblasts and maternal cells via killer cell immunoglobulin-like receptors (KIRs) provides two-way tuning (education) of decidual natural killer cells (dNK) with the appearance of allo- (HvG) and autoreactive (HvH) dNK. Disturbances in dNK HvG and dNK HvH representation may lead to abnormalities in placental development and pregnancy pathology. Our data show that recurrent pregnancy loss is not associated with specific HLA and KIR genotypes in mother and fetus, although the peculiarities of tuning involving KIR3DL2 may affect pregnancy outcome. Mathematical modeling shows the dependence of dNK HvG and dNK HvH representation on the probability of random KIR gene expression. The new description of NK cell involvement in the immune response in the placenta via two-way tuning is applicable to all cases where there are target cells with normal and different “guest” HLA expression (viral infections, tumors, etc.) Graphic abstract (Cover work): Image of fetus in utero in graphic abstract adapted from Servier Medical Art ( https://smart.servier.com ), licensed under CC BY 4.0 ( https://creativecommons.org/licenses/by/4.0/ ) Highlights: A hypothesis has been proposed according to which random expression of NK cell receptor genes in combination with two-way tuning (education) of NK cells by different affinity pairs of inhibitory killer cell immunoglobulin-like receptors (KIRs) and their ligands on decidual cells and trophoblasts leads to the presence of populations of maternal decidual NK cells with allo- and autoreactivity in the placenta. It has been shown that the features of the HLA and KIR genotypes of the mother and fetus are not the underlying cause of habitual miscarriage, although genetic features can affect the course of pregnancy. Model calculations of the representation of auto- and alloreactive maternal decidual NK cells show that the effectiveness of their participation in the structural and functional reorganization of the placenta should depend on the probability of KIR gene expression. The hypothesis of two-way tuning of NK cells in the presence of different target cells with normal and different “guest” HLA expressions is applicable to describe the involvement of the innate immune system in the response to pregnancy, viral infection, inflammation, wounds, tumors, and transplantation.
- 30 November 2024
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 11_2024, 98-108
Natural killer cell immunoglobulin-like receptors and their ligands in spouses and pregnancy outcomes of recurrent miscarriage treated with immunocytic therapy
- 30 November 2024
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 11_2024, 98-108
Natural killer cell immunoglobulin-like receptors and their ligands in spouses and pregnancy outcomes of recurrent miscarriage treated with immunocytic therapy
- 21 September 2024
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 209 (2) , 341-354
HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles
Purpose Female carriers of germline BRCA1 mutations almost invariably develop breast cancer (BC); however, the age at onset is a subject of variation. We hypothesized that the age-related penetrance of BRCA1 mutations may depend on inherited variability in the host immune system. Methods Next-generation sequencing was utilized for genotyping of HLA class I/II genes (HLA-A, HLA-B, HLA-C, HLA-DPB1, HLA-DQB1, and HLA-DRB1/3/4/5) in patients with BRCA1-associated BC with early (< / = 38 years, n = 215) and late (> / = 58 years, n = 108) age at onset. Results HLA-DQB1*06:03P prevalence was higher in the late-onset group due to the excess of allele carriers [25/108 (23.1%) vs. 22/215 (10.2%); OR 2.96, p < 0.001]. For all HLA-I loci, there was a trend toward an increase in the number of homozygotes in the early-onset group. This trend reached statistical significance for the HLA-A [14.4% vs. 6.5%, p = 0.037; OR 2.4, p = 0.042]. The frequencies of HLA-DPB1, HLA-DQB1, and HLA-DRB1/3/4/5 homozygous genotypes did not differ between young-onset and late-onset patients. The maximum degree of homozygosity detected in this study was 6 out of 7 HLA class I/II loci; all six carriers of these genotypes were diagnosed with BC at the age < / = 38 years [OR 6.97, p = 0.187]. Conclusion HLA polymorphism may play a role in modifying the penetrance of BRCA1 pathogenic variants. Certain HLA alleles or HLA homozygosity may modify the risk of BC in BRCA1 carriers.
- 21 September 2024
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 209 (2) , 341-354
HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles
Purpose Female carriers of germline BRCA1 mutations almost invariably develop breast cancer (BC); however, the age at onset is a subject of variation. We hypothesized that the age-related penetrance of BRCA1 mutations may depend on inherited variability in the host immune system. Methods Next-generation sequencing was utilized for genotyping of HLA class I/II genes (HLA-A, HLA-B, HLA-C, HLA-DPB1, HLA-DQB1, and HLA-DRB1/3/4/5) in patients with BRCA1-associated BC with early (< / = 38 years, n = 215) and late (> / = 58 years, n = 108) age at onset. Results HLA-DQB1*06:03P prevalence was higher in the late-onset group due to the excess of allele carriers [25/108 (23.1%) vs. 22/215 (10.2%); OR 2.96, p < 0.001]. For all HLA-I loci, there was a trend toward an increase in the number of homozygotes in the early-onset group. This trend reached statistical significance for the HLA-A [14.4% vs. 6.5%, p = 0.037; OR 2.4, p = 0.042]. The frequencies of HLA-DPB1, HLA-DQB1, and HLA-DRB1/3/4/5 homozygous genotypes did not differ between young-onset and late-onset patients. The maximum degree of homozygosity detected in this study was 6 out of 7 HLA class I/II loci; all six carriers of these genotypes were diagnosed with BC at the age < / = 38 years [OR 6.97, p = 0.187]. Conclusion HLA polymorphism may play a role in modifying the penetrance of BRCA1 pathogenic variants. Certain HLA alleles or HLA homozygosity may modify the risk of BC in BRCA1 carriers.
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 45 (6)
Association of pregnancy outcomes after immunocytotherapy of recurrent pregnancy loss with genotypes of killer cell immunoglobulin-like receptors and their ligands in mother and fetus
Связь исходов беременности при иммуноцитотерапии привычного выкидыша с генотипами иммуноглобулиноподобных рецепторов клеток-киллеров и их лигандов у
- 1 January 2024
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 45 (6)
Open AccessAssociation of pregnancy outcomes after immunocytotherapy of recurrent pregnancy loss with genotypes of killer cell immunoglobulin-like receptors and their ligands in mother and fetus
Связь исходов беременности при иммуноцитотерапии привычного выкидыша с генотипами иммуноглобулиноподобных рецепторов клеток-киллеров и их лигандов у
- Open Access
41P HLA genotypes modify the age-related penetrance of BRCA1 pathogenic variants in breast cancer patients
- Open Access
- 1 January 2018
- Published by Pirogov Russian National Research Medical University in Bulletin of Russian State Medical University
- No. 3,p. 29-33
Quantification of fetal DNA in the plasma of pregnant women using next generation sequencing of frequent single nucleotide polymorphisms
- 1 January 2018
- Published by Pirogov Russian National Research Medical University in Bulletin of Russian State Medical University
- No. 3,p. 29-33
Open AccessQuantification of fetal DNA in the plasma of pregnant women using next generation sequencing of frequent single nucleotide polymorphisms